Dipeptide-Repeat Vaccine to prevent ALS and FTD in C9orf72 mutation carriers

Project Information

DPR-VAX

Grant agreement ID: 875677

DOI

10.3030/875677

Project closed

EC signature date 10 December 2019

Start date 1 March 2020

End date 31 May 2022

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost

No data

EU contribution

€ 150 000,00

Coordinated by

DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN EV
Germany

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

Chronic T cell proliferation in brains after stroke could interfere with the efficacy of immunotherapies.

Author(s): Heindl, Steffanie; Ricci, Alessio; Carofiglio, Olga; Zhou, Qihui; Arzberger, Thomas; Lenart, Nikolett; Franzmeier, Nicolai; Hortobagyi, Tibor; Nelson, Peter T.; Stowe, Ann M.; Denes, Adam; Edbauer, Dieter; Liesz, Arthur
Published in: The Journal of Experimental Medicine, Issue 15409538, 2021, ISSN 1540-9538
Publisher: Rockefeller University Press
DOI: 10.1084/jem.20202411

Intellectual Property Rights

Patent (1)

IMMUNOGEN FOR PREVENTING OR TREATING FAMILIAL FRONTOTEMPORAL DEMENTIA (FTD) AND/OR AMYOTROPHIC LATERAL SCLEROSIS (ALS)

Application/Publication number: 20 20062343
Date: 2020-05-04
Applicant(s): DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN EV